DexCom: Stay Sweet or Go Sour?
September 28, 2017 at 11:00 AM EDT
Shares of DexCom are getting crushed following news that Abbott Laboratories received approval for a rival glucose monitor for diabetics. But some analysts see this as a buying opportunity.
